Suppr超能文献

重复随机血糖测量作为妊娠期糖尿病的通用筛查试验。

Repeated random blood glucose measurements as universal screening test for gestational diabetes mellitus.

作者信息

Ostlund Ingrid, Hanson Ulf

机构信息

Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.

出版信息

Acta Obstet Gynecol Scand. 2004 Jan;83(1):46-51. doi: 10.1111/j.1600-0412.2004.00267.x.

Abstract

BACKGROUND

To determine the value of repeated random blood glucose (R-B-glucose) measurements alone or in combination with traditional risk factors [family history of diabetes, obesity, prior large-for-gestational-age (LGA) infant or prior gestational diabetes mellitus (GDM)] to predict the outcome of the oral glucose tolerance test (OGTT).

METHODS

A prospective population-based study was undertaken in a Swedish county. All pregnant nondiabetic women (n = 4918) visiting the maternal health care clinics over a 2-year period were offered a 75-g OGTT in gestational weeks 28-32. Traditional risk factors and values of repeated R-B-glucose measurements were registered, as well as the results of the OGTT, in terms of fasting B-glucose and 2-h B-glucose.

RESULTS

A total of 3616 women (73.5%) had an OGTT. Of these, 1.7% had GDM, 1.3% impaired glucose tolerance (IGT) and 0.4% diabetes mellitus (DM). An R-B-glucose cut-off level > or =8.0 mmol/L as the only indicator for an OGTT was optimal for detecting GDM with regard to sensitivity (47.5%) and specificity (97.0%). It has the same sensitivity for detecting GDM as using traditional risk factors, but reduces the need to carry out the OGTT from 15.8% to 3.8% of the population. Combined with prior LGA infant or prior GDM as indications for the OGTT in the present study, all women with DM and 44.7% of those with IGT will be identified. Only 7.3% of the population will have to take the OGTT.

CONCLUSION

A random B-glucose level > or = 8.0 mmol/L prior LGA infant or prior GDM as an indicator for taking the OGTT is a simple and effective first step in a two-step screening model for GDM.

摘要

背景

确定单独重复测定随机血糖(R-B-葡萄糖)或联合传统危险因素[糖尿病家族史、肥胖、既往巨大儿(LGA)或既往妊娠期糖尿病(GDM)]预测口服葡萄糖耐量试验(OGTT)结果的价值。

方法

在瑞典一个县进行了一项基于人群的前瞻性研究。在两年期间到产妇保健诊所就诊的所有非糖尿病孕妇(n = 4918)在妊娠28 - 32周时接受75g OGTT。记录传统危险因素、重复R-B-葡萄糖测定值以及OGTT结果,包括空腹B-葡萄糖和2小时B-葡萄糖。

结果

共有3616名妇女(73.5%)进行了OGTT。其中,1.7%患有GDM,1.3%葡萄糖耐量受损(IGT),0.4%患有糖尿病(DM)。以R-B-葡萄糖截断水平≥8.0 mmol/L作为OGTT的唯一指标,在检测GDM方面,敏感性(47.5%)和特异性(97.0%)最佳。其检测GDM的敏感性与使用传统危险因素相同,但将进行OGTT人群的比例从15.8%降至3.8%。在本研究中,联合既往巨大儿或既往GDM作为OGTT的指征,可识别所有患有DM的妇女以及44.7%患有IGT的妇女。仅7.3%的人群需要进行OGTT。

结论

随机B-葡萄糖水平≥8.0 mmol/L、既往巨大儿或既往GDM作为进行OGTT的指标,是GDM两步筛查模型中简单有效的第一步。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验